These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 11941942)

  • 21. Screening of patients with a positive family history of colorectal cancer.
    Burt RW
    Gastrointest Endosc Clin N Am; 1997 Jan; 7(1):65-79. PubMed ID: 8995113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal adenomatous polyps detected by immunochemical occult blood screening.
    Fattah AS; Nakama H; Kamijo N; Fujimori K; Zhang B
    Hepatogastroenterology; 1998; 45(21):712-6. PubMed ID: 9684121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A; Young GP; Cole SR; Bampton P
    Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Screening for colorectal neoplasms].
    Shani A; Rozen P; Fink A; Bass D; Levy E; Fireman Z; Gottesfeld F; Baker S; Fraizer D; Bentwich Z
    Harefuah; 1990 Jan; 118(2):66-70. PubMed ID: 2179072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-degree relatives of patients with advanced colorectal adenomas have an increased prevalence of colorectal cancer.
    Lynch KL; Ahnen DJ; Byers T; Weiss DG; Lieberman DA
    Clin Gastroenterol Hepatol; 2003 Mar; 1(2):96-102. PubMed ID: 15017501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population colorectal cancer screening with fecal occult blood test.
    Rennert G; Rennert HS; Miron E; Peterburg Y
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1165-8. PubMed ID: 11700264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitivity of immunochemical fecal occult blood test for colorectal flat adenomas.
    Nakama H; Zhang B; Kamijo N
    Hepatogastroenterology; 2004; 51(59):1333-6. PubMed ID: 15362746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of colorectal cancer in relatives: a case control study.
    Safaee A; Moghimi-Dehkordi B; Pourhoseingholi MA; Vahedi M; Maserat E; Ghiasi S; Fatemi SR; Zali MR
    Indian J Cancer; 2010; 47(1):27-30. PubMed ID: 20071786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal cancer screening and familial risk: a survey of internal medicine residents' knowledge and practice patterns.
    Barrison AF; Smith C; Oviedo J; Heeren T; Schroy PC
    Am J Gastroenterol; 2003 Jun; 98(6):1410-6. PubMed ID: 12818289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Screening for colorectal cancer in high-risk and intermediate-risk subject: what's the best tool?].
    Trevisani L; Cifalà V; Sartori S; Tombesi P; Matarese V; Pezzoli A; Abbasciano V
    Recenti Prog Med; 2009 Feb; 100(2):68-72. PubMed ID: 19350797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A scoring system for the strength of a family history of colorectal cancer.
    Church JM
    Dis Colon Rectum; 2005 May; 48(5):889-96. PubMed ID: 15785893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colorectal cancer screening through detection of fecal occult blood in a controlled health zone.
    Tárraga P; García-Olmo D; Celada A; García-Molinero Mf; Divison JA; Casado C
    Rev Esp Enferm Dig; 1999 May; 91(5):335-44. PubMed ID: 10362875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Family history of colorectal adenomatous polyps as a risk factor for colorectal cancer.
    Nakama H; Zhang B; Fukazawa K; Abdul Fattah AS
    Eur J Cancer; 2000 Oct; 36(16):2111-4. PubMed ID: 11044649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Early detection of colorectal carcinoma. Pros and cons].
    von Betzler M
    MMW Fortschr Med; 2005 Apr; 147(14):26-8. PubMed ID: 15887679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic significance of immunohistochemical fecal occult blood test in subjects receiving bidirectional endoscopy.
    Liu HH; Huang TW; Chen HL; Wang TH; Lin JT
    Hepatogastroenterology; 2003; 50(53):1390-2. PubMed ID: 14571744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Performance of the Hemoccult test in the screening of colorectal cancer and adenoma. Results of 5 screening campaigns in Saône-et-Loire].
    Tazi MA; Faivre J; Lejeune C; Benhamiche AM; Dassonville F
    Gastroenterol Clin Biol; 1999 May; 23(5):475-80. PubMed ID: 10429850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Family-based screening for colorectal cancer: The Australian perspective.
    Leggett BA
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S29-32. PubMed ID: 19799695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detecting colorectal cancer with a large scale fecal occult blood testing program.
    Gregorio DI; Lolachi P; Hansen H
    Public Health Rep; 1992; 107(3):331-5. PubMed ID: 1594743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal occult blood test performance indicators in warfarin-treated patients.
    Kershenbaum A; Lavi I; Rennert G; Almog R
    Dis Colon Rectum; 2010 Feb; 53(2):224-9. PubMed ID: 20087099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.